carbostyril has been researched along with Chronic Disease in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 44 (48.89) | 18.2507 |
2000's | 25 (27.78) | 29.6817 |
2010's | 15 (16.67) | 24.3611 |
2020's | 6 (6.67) | 2.80 |
Authors | Studies |
---|---|
Almirante, B; Bosch-Nicolau, P; Burgos, J; Marquez-Algaba, E; Pigrau, C; Serra-Pladevall, J; Viñado, B | 1 |
Cai, J; Gao, M; Huang, J; Huang, Y; Kang, D; Li, L; Liu, F; Long, Y; Ou, J; Peng, X; Shao, P; Shao, T; Shen, Y; Song, C; Su, Y; Sun, M; Wang, W; Wang, X; Wu, Q; Wu, R; Xiao, J; Xie, P; Yang, Y | 1 |
Allen, M; Cho, DY; Elder, JB; Grayson, JW; Lim, DJ; McCormick, J; McLemore, JG; Rowe, SM; Skinner, D; West, JM; Woodworth, BA; Zhang, S | 1 |
González-Garay, A; Ochoa-Hein, E; Rivera-Luna, R; Velasco-Hidalgo, L | 1 |
Daniels, MLA; Ebert, CS; Farzal, Z; Kimple, AJ; Lee, SE; Senior, BA; Thorp, BD; Zanation, AM | 1 |
Gao, HL; Jiang, TT; Liu, C; Wang, SY; Wang, ZH; Zhang, C; Zhang, HX; Zhang, MP; Zhu, WT | 1 |
Bhutta, MF; Brennan-Jones, CG; Burton, MJ; Chong, LY; Daw, J; Head, K; Richmond, P; Schilder, AG; Snelling, T; Webster, KE | 1 |
Bleeker-Rovers, CP; de Regt, MJA; Hoepelman, AIM; Kampschreur, LM; Oosterheert, JJ; van Roeden, SE; Wever, PC | 1 |
Alexander, DK; Cho, DY; Grayson, JW; Hill, HS; Lim, DJ; Mackey, C; Peña Garcia, JA; Skinner, D; Weeks, CG; Woodworth, BA; Zhang, S | 1 |
Bonk, MP; Hadjiliadis, D; Rey, MM | 1 |
Cho, DY; Hathorne, H; Lampkin, B; McCormick, J; Richman, J; Rowe, SM; Woodworth, BA | 1 |
Pitchot, W | 1 |
Chalkiadakis, VF; Kotzampasakis, DS; Nikolopoulos, TP; Tsilis, NS; Vlastarakos, PV | 1 |
Cho, SJ; Choi, JH; Hahn, SW; Han, C; Jeon, HJ; Jon, DI; Jun, TY; Kim, SG; Kim, W; Kwak, KP; Lee, BC; Pae, CU; Park, EJ; Seo, HJ | 1 |
Pierris, N; Stamatiou, K | 1 |
Adham, N; Gruca, P; Gyertyán, I; Kiss, B; Lasoń-Tyburkiewicz, M; Papp, M | 1 |
Abou Alaiwa, MH; Chang, EH; Ernst, SE; Graham, SM; Hilkin, B; Hornick, DB; Karp, PH; Launspach, JL; Shah, VS; Stoltz, DA; Tang, XX; Welsh, MJ; Zabner, J | 1 |
Cho, SI; Choi, JA; Jang, SJ; Jo, ER; Sim, JH; Youn, CK | 1 |
Sikich, L | 1 |
Gripeos, D; Sokolski, KN | 1 |
Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, AL; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
Barosi, G; Rosti, V | 1 |
Lai, CH | 1 |
Fujino, J; Tabushi, K; Tanaka, H; Taniguchi, N | 1 |
Gen, K; Inoue, Y; Suzuki, H | 1 |
Jean-Baptiste, M; Mukai, Y; Two, A | 1 |
Naber, KG | 2 |
Carson, WH; Ingenito, GG; Pigott, TA; Saha, AR; Stock, EG; Torbeyns, AF | 1 |
Duggal, HS | 1 |
DeQuardo, JR | 1 |
Goforth, HW; Rao, M; Sucholeiki, R | 1 |
Artemenko, N; Gorelov, A; Perekalina, T; Smelov, V; Smelova, N; Ukleeva, G | 1 |
Odenike, O; Tefferi, A | 1 |
Acuin, JM; Gamble, C; Macfadyen, CA | 1 |
Axelsson, B; Leanderson, T; Ohlsson, L; Runström, A | 1 |
Caney, SM; Day, MJ; Dean, RS; Gruffydd-Jones, TJ; Helps, CR; Knowles, TG; Lait, PJ; Pinches, MD; Tasker, S | 1 |
Fernald, DS; Hovens, JE; Loonen, AJ; van Dellen, RT | 1 |
Thomas, P | 1 |
Calais, LA; Cañive, JM; Lundy, SL; Pickard, J; Toney, G; Villarreal, G | 1 |
Barbone, F; De Maria, M; Giannarini, G; Manassero, F; Mogorovich, A; Morelli, G; Selli, C; Valent, F | 1 |
Klein, J; Krüger, S; Sarkar, R | 1 |
Bai, DS; Sea, HS; Seo, WS; Sung, HM | 1 |
Chitapanarux, T; Lertprasertsuke, N; Praisontarangkul, OA | 1 |
Davis, S; Ewbank, AJ; Threlfall, EJ; Wall, PG; Ward, LR | 1 |
Bauer, J; Budeanu, C; Hof, H; Kretschmar, M; Linss, W; Nichterlein, T | 1 |
Arakawa, S; Ban, Y; Hirose, T; Ito, Y; Kamidono, S; Kawada, Y; Kumamoto, Y; Kumon, H; Ohmori, H; Suzuki, K | 1 |
Nameta, K; Sasaki, J | 1 |
Cesana, M; Focht, J; Klietmann, W; Rondel, RK | 1 |
Berche, P; Gaillot, O | 1 |
Chida, K; Hayakawa, H; Iwata, M; Kitazawa, H; Sato, A | 2 |
Hirao, Y; Iinuma, S; Kondo, M; Miyazaki, R; Naito, Y; Osumi, T; Yagi, N; Yoshida, N; Yoshikawa, T | 1 |
Farca, AM; Nebbia, P; Re, G; Robino, P | 1 |
Breisch, S; Chodosh, S; Lakshminarayan, S; Swarz, H | 1 |
Amantea, MA; Chodosh, S; Collins, DA; Forrest, A; Schentag, JJ | 1 |
Breisch, S; Cranfield, R; Langan, CE; Pettit, R | 1 |
Brumbaugh, GW; Lizarraga, RE; Ocampo, CL; Sumano, LH | 1 |
Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
Iwai, A; Iwashita, E | 1 |
Bykova, AV; Emel'ianov, AV; Fedoseev, GB; Rudinskiĭ, KA; Shevelev, SE | 1 |
Iakovlev, SV | 1 |
Bagby, B; Bettis, R; Collins, JJ; DeAbate, CA; Fleming, H; Giguere, G; Munk, ZM; Munn, NJ; Riffer, E | 1 |
El'kun, GB | 1 |
Greenberg, RN; Newman, MT; Pectol, RW; Shariaty, S | 1 |
Belousov, IuB; Efremenkova, OV; Sokolov, AV; Tishenkova, IF | 1 |
González Lama, Z; Lupiola Gómez, P; Martín Barrasa, JL; Tejedor Junco, MT | 1 |
Dionisio, P; Grassi, C; Rosignoli, MT; Salvatori, E | 1 |
Albera, C; Grassi, C; Pozzi, E | 1 |
Ellison, WT; Gotfried, MH | 1 |
Kemper, P; Köhler, D | 1 |
Cook, DJ | 1 |
Stempel, DA; Szefler, SJ | 1 |
Drennan, C; Holst, P; Jones, D; Rea, H; Thornley, P; Wells, A | 1 |
Glerum, JH; Hoepelman, AI; Kovarik, JM; Rozenberg-Arska, M; Sips, PA; Smit, JM; Verhoef, J | 1 |
Arakawa, S; Kamidono, S | 1 |
Dahl, R; Haahtela, T | 1 |
Derevnianko, II; Kondrat'eva, EM; Kotliarova, GA; Perepanova, TS; Siniukhin, VN; Ukhin, AV | 1 |
Elegant, VA | 1 |
Bischoff, W; Boerema, JB; Focht, J; Naber, KG | 1 |
Chodosh, S | 1 |
Bischoff, W; Blenk, H; Boerema, JB; Carpentier, P; Focht, J; Naber, KG; Sylvester, J | 1 |
Petzinger, E | 1 |
Cremers, HM; Davies, BI; Gubbelmans, HL; Maesen, FP | 1 |
Clague, J; Davies, RJ; Gatland, D; Gomez, E; Lozewicz, S | 1 |
Boulet, LP; Cartier, A; Cockcroft, D; Gruber, J; Keshmiri, M; Kesten, S; Laberge, F; Lee-Chuy, E; MacDonald, GF; Rebuck, AS | 1 |
Magnussen, H | 1 |
Kot, T; Pettit-Young, N | 1 |
18 review(s) available for carbostyril and Chronic Disease
Article | Year |
---|---|
Efficacy and safety of quinolones for the treatment of uncomplicated urinary tract infections in women: a network meta-analysis.
Topics: Anti-Bacterial Agents; Chronic Disease; Female; Humans; Network Meta-Analysis; Quinolones; Urinary Tract Infections | 2021 |
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Chronic Disease; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Approval; Humans; Indoles; Mutation; Nasal Mucosa; Otolaryngologists; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2020 |
[Efficacy, safety and cost of Qianlieshutong Capsules in the treatment of chronic prostatitis].
Topics: Capsules; Chronic Disease; Drugs, Chinese Herbal; Humans; Male; Prostatitis; Quinolones; Randomized Controlled Trials as Topic | 2019 |
Topical versus systemic antibiotics for chronic suppurative otitis media.
Topics: Administration, Topical; Adult; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bias; Child; Chronic Disease; Humans; Ofloxacin; Otitis Media, Suppurative; Quinolones; Randomized Controlled Trials as Topic; Time Factors | 2021 |
Chronic otitis media in children: an evidence-based guide for diagnosis and management.
Topics: Anti-Bacterial Agents; Child; Chronic Disease; Evidence-Based Medicine; Humans; Otitis Media; Practice Guidelines as Topic; Quinolones | 2013 |
Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Diseases; Child; Chronic Disease; Clozapine; Comorbidity; Disease Progression; Humans; Magnetic Resonance Imaging; Olanzapine; Piperazines; Prognosis; Psychotic Disorders; Quinolones; Schizophrenia; Thiazoles; Treatment Failure | 2008 |
Novel strategies for patients with chronic myeloproliferative disorders.
Topics: Chronic Disease; Humans; Interferon alpha-2; Interferon-alpha; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Quinolones; Recombinant Proteins; Thalidomide | 2009 |
Conventional and new treatment options for myelofibrosis with myeloid metaplasia.
Topics: Androgens; Angiogenesis Inhibitors; Antineoplastic Agents; Azacitidine; Benzamides; Chronic Disease; Decitabine; Erythropoietin; Humans; Imatinib Mesylate; Piperazines; Primary Myelofibrosis; Pyrimidines; Quinolones; Recombinant Proteins | 2005 |
Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Chronic Disease; Developing Countries; Hearing Disorders; Humans; Otitis Media, Suppurative; Quinolones; Randomized Controlled Trials as Topic; Tympanic Membrane Perforation | 2005 |
The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.
Topics: Antipsychotic Agents; Aripiprazole; Chronic Disease; Humans; Metabolic Syndrome; Patient Compliance; Piperazines; Quinolones; Schizophrenia; Schizophrenic Psychology | 2007 |
[Chronic osteomyelitis of mandibulae].
Topics: Ampicillin; Cephalosporins; Chronic Disease; Humans; Mandible; Mandibular Diseases; Osteomyelitis; Quinolones; Streptococcal Infections | 1994 |
Management of chronic asthma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchodilator Agents; Child; Chronic Disease; Cromolyn Sodium; Desensitization, Immunologic; Drug Therapy, Combination; Glucocorticoids; Humans; Nedocromil; Quinolones | 1992 |
Prophylactic pharmacologic treatment of asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Chronic Disease; Cromolyn Sodium; Humans; Nedocromil; Quinolones; Steroids | 1992 |
The role of quinolones in the treatment of chronic bacterial prostatitis.
Topics: Bacterial Infections; Body Fluids; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Prostatitis; Quinolones | 1991 |
Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Quinolones | 1991 |
[Gyrase inhibitors, a new class of therapeutic drugs].
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Quinolones; Respiratory Tract Diseases | 1991 |
[Hypersensitivity of the respiratory tract: determination, occurrence and clinical significance].
Topics: Adrenal Cortex Hormones; Allergens; Asthma; Bronchitis; Chronic Disease; Humans; Ketotifen; Nedocromil; Quinolones; Respiratory Hypersensitivity | 1990 |
Acute and chronic bacterial prostatitis: a review of treatment approaches.
Topics: Acute Disease; Bacterial Infections; Chronic Disease; Humans; Male; Prostatitis; Quinolones | 1990 |
36 trial(s) available for carbostyril and Chronic Disease
Article | Year |
---|---|
Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre study.
Topics: Adult; Antidepressive Agents; Aripiprazole; Chronic Disease; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Secondary Prevention; Treatment Outcome | 2013 |
Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study.
Topics: Adult; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Prostatitis; Quinolones; Serenoa; Time Factors | 2013 |
Results of phase 3 of the CATIE schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Female; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2009 |
An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Attention; Benzodiazepines; Chronic Disease; Cognition Disorders; Dose-Response Relationship, Drug; Drug Substitution; Executive Function; Female; Humans; Isoindoles; Longitudinal Studies; Male; Memory; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Single-Blind Method; Thiazoles; Time Factors; Verbal Learning | 2011 |
Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Fluoroquinolones; Humans; Male; Prostatitis; Pseudomonas; Quinolones; Treatment Outcome; Urinary Tract Infections | 2002 |
Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chronic Disease; Double-Blind Method; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome | 2003 |
Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chronic Disease; Combat Disorders; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Personality Assessment; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2007 |
Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Dioxolanes; Double-Blind Method; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Piperazines; Prospective Studies; Prostatitis; Quinolones | 2007 |
Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Mass Index; Body Weight; Child; Chronic Disease; Female; Humans; Male; Piperazines; Quinolones; Tics; Tourette Syndrome; Treatment Outcome | 2008 |
An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.
Topics: Adult; Alanine; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Endoscopy, Gastrointestinal; Endpoint Determination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Quinolones; Thailand; Young Adult | 2008 |
[Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones | 1994 |
Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Sputum | 1993 |
Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Chronic Disease; Female; Gastric Mucosa; Gastritis; Humans; Male; Middle Aged; Quinolones | 1996 |
Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Bronchodilator Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Theophylline; Treatment Outcome | 1998 |
Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Male; Middle Aged; Models, Biological; Piperazines; Quinolones; Time Factors | 1997 |
Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Piperazines; Quinolones; Treatment Outcome | 1997 |
Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Chronic Disease; Disease Outbreaks; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Mycoplasma Infections; Nicotinic Acids; Norfloxacin; Poultry Diseases; Probability; Quinolones; Respiratory Tract Infections; Survival Analysis | 1998 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
[Efficacy of lomefloxacin in treatment of patients with chronic bronchitis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moraxella catarrhalis; Neisseria; Quinolones; Roxithromycin; Sputum; Staphylococcus aureus; Streptococcus | 1998 |
[Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
Topics: Age Factors; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1998 |
Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Quinolones | 1999 |
[Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antitubercular Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Quinolones; Sinusitis; Treatment Outcome | 1999 |
Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Osteomyelitis; Quinolones | 2000 |
[The importance of fluoroquinolones in treating pneumonia in the elderly].
Topics: Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Quinolones; Sputum; Time Factors | 1999 |
Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Dioxolanes; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome | 2002 |
Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic Disease; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Quinolones; Recurrence; Treatment Outcome | 1992 |
Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefaclor; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Recurrence; Single-Blind Method; Treatment Outcome | 1992 |
A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Quinolones; Treatment Outcome | 1992 |
Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nedocromil; Patient Dropouts; Quinolones; Steroids | 1992 |
Assessment of the UTI criteria for bacterial prostatitis in Japan.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones; Treatment Outcome | 1992 |
An open multicentre study on the efficacy and safety of rufloxacin in patients with chronic bacterial prostatitis.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones | 1991 |
An assessment of temafloxacin in the treatment of chronic bacterial prostatitis.
Topics: Administration, Oral; Anti-Infective Agents; Chronic Disease; Fluoroquinolones; Humans; Male; Prostatitis; Quinolones | 1991 |
Temafloxacin in acute purulent exacerbations of chronic bronchitis.
Topics: 4-Quinolones; Anti-Infective Agents; Bronchitis; Chronic Disease; Drug Administration Schedule; Fluoroquinolones; Haemophilus influenzae; Humans; Moraxella catarrhalis; Pseudomonas aeruginosa; Quinolones; Sputum; Streptococcus pneumoniae | 1990 |
Allergen-induced changes in the nasal mucous membrane in seasonal allergic rhinitis: effect of nedocromil sodium.
Topics: Adult; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Chronic Disease; Drug Evaluation; Eosinophils; Epithelium; Female; Humans; Leukocyte Count; Male; Mast Cells; Middle Aged; Nasal Mucosa; Nedocromil; Quinolones; Rhinitis, Allergic, Seasonal | 1990 |
A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Canada; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nedocromil; Peak Expiratory Flow Rate; Quinolones; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Acute and chronic bacterial prostatitis: a review of treatment approaches.
Topics: Acute Disease; Bacterial Infections; Chronic Disease; Humans; Male; Prostatitis; Quinolones | 1990 |
37 other study(ies) available for carbostyril and Chronic Disease
Article | Year |
---|---|
Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; beta-Lactams; Chronic Disease; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Prostatitis; Pyelonephritis; Quinolones; Recurrence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chronic Disease; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quinolones; Recurrence; Schizophrenia | 2023 |
Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.
Topics: Aminophenols; Animals; Chronic Disease; Ciprofloxacin; Maxillary Sinus; Pseudomonas; Pseudomonas Infections; Quinolones; Rabbits; Sinusitis; Stents | 2020 |
Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens.
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Coxiella burnetii; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Q Fever; Quinolones; Retrospective Studies; Tetracyclines; Treatment Failure | 2018 |
l-Methionine anti-biofilm activity against Pseudomonas aeruginosa is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor.
Topics: Aminophenols; Anti-Bacterial Agents; Biofilms; Chronic Disease; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Methionine; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rhinitis; Sinusitis | 2018 |
Cystic Fibrosis: Emerging Understanding and Therapies.
Topics: Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Chronic Disease; Combined Modality Therapy; Comprehension; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Management; Disease Progression; Drug Approval; Female; Genetic Predisposition to Disease; Humans; Lung Transplantation; Male; Prognosis; Quinolones; Risk Assessment; Severity of Illness Index; Survival Analysis; United States; United States Food and Drug Administration | 2019 |
Ivacaftor improves rhinologic, psychologic, and sleep-related quality of life in G551D cystic fibrosis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminophenols; Child; Chronic Disease; Cohort Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Mental Health; Middle Aged; Mutation; Prospective Studies; Quality of Life; Quinolones; Rhinitis; Sinusitis; Sleep; Surveys and Questionnaires; Young Adult | 2019 |
[Is there a place for the physician's hopelesness in the treatment of depression?].
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Physician's Role; Piperazines; Quinolones; Remission Induction; Risk Factors; Thiophenes; Treatment Outcome | 2013 |
Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression.
Topics: Anhedonia; Animals; Antidepressive Agents; Aripiprazole; Chronic Disease; Depressive Disorder; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Imipramine; Male; Piperazines; Quinolones; Rats, Wistar; Stress, Psychological | 2014 |
Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor.
Topics: Aminophenols; Anti-Inflammatory Agents; Cells, Cultured; Child; Chronic Disease; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Hydrogen-Ion Concentration; Ion Transport; Mutation; Quinolones; Respiratory Mucosa; Sinusitis; Treatment Outcome; Viscosity | 2015 |
Comparative antibacterial activity of topical antiseptic eardrops against methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Topics: Acetates; Acetic Acid; Administration, Topical; Anti-Infective Agents, Local; Boric Acids; Chronic Disease; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Otitis Media, Suppurative; Pharmaceutical Solutions; Pseudomonas aeruginosa; Quinolones | 2016 |
Remission of chronic severe selective serotonin-reuptake inhibitor/selective norepinephrine-reuptake inhibitor refractory depression following adjunctive aripiprazole.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Depression; Drug Therapy, Combination; Female; Humans; Middle Aged; Norepinephrine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2008 |
Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Chronic Disease; Dizziness; Dopamine Agents; Drug Resistance; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Psychiatric Status Rating Scales; Quinolones; Tic Disorders; Treatment Outcome | 2009 |
Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia, Paranoid | 2010 |
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Dopamine Agents; Female; Fluvoxamine; GABA Modulators; Humans; Lorazepam; Memantine; Neurosurgical Procedures; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2011 |
Aripiprazole-induced improvement in tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chronic Disease; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Psychotic Disorders; Quinolones; Severity of Illness Index | 2003 |
Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?
Topics: Anger; Antipsychotic Agents; Aripiprazole; Chronic Disease; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia | 2004 |
Chronic interictal psychosis responsive to aripiprazole.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Chronic Disease; Clonazepam; Delusions; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy, Complex Partial; Epilepsy, Temporal Lobe; Female; Humans; Lamotrigine; Paranoid Disorders; Piperazines; Quinolones; Treatment Outcome; Triazines | 2004 |
Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Chronic Disease; Fluoroquinolones; Humans; Levofloxacin; Male; Ofloxacin; Prostatitis; Quinolones | 2005 |
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
Topics: Animals; Central Nervous System; Chronic Disease; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Immunohistochemistry; Interferon-beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Polymerase Chain Reaction; Quinolones | 2006 |
Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Colony Count, Microbial; Feline Acquired Immunodeficiency Syndrome; Female; Fluoroquinolones; Male; Mycoplasma; Mycoplasma Infections; Polymerase Chain Reaction; Quinolones; Random Allocation; Time Factors; Treatment Outcome; Viral Load | 2006 |
Aripiprazole in chronic schizophrenia: experiences in daily practice.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chronic Disease; Female; Humans; Male; Piperazines; Quinolones; Schizophrenia; Time Factors | 2006 |
Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Topics: Antipsychotic Agents; Aripiprazole; Chronic Disease; Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior | 2008 |
Chronic carriage of multidrug resistant Salmonella typhimurium in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Drug Resistance, Microbial; Drug Resistance, Multiple; Enrofloxacin; Feces; Female; Fluoroquinolones; Gastroenteritis; Quinolones; Salmonella Infections; Salmonella typhimurium | 1995 |
Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells.
Topics: Ampicillin; Animals; Anti-Infective Agents; Cell Line; Chronic Disease; Female; Fluoroquinolones; Interferon-gamma; Interleukin-6; Listeria monocytogenes; Listeriosis; Liver; Mice; Mice, Nude; Microbial Sensitivity Tests; Microscopy, Electron; Quinolones; Spleen | 1994 |
Breakpoint determination: rufloxacin.
Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections | 1993 |
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media; Quinolones; Sinusitis | 1995 |
Study of the effects of AM-1155 in a rat chronic respiratory tract infection model with Pseudomonas aeruginosa.
Topics: Animals; Anti-Infective Agents; Chronic Disease; Fluoroquinolones; Gatifloxacin; Immunoglobulin A; Lung; Lymphoid Tissue; Male; Piperazines; Pseudomonas Infections; Quinolones; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections | 1995 |
Effect of 6-fluoro-8-methoxy quinolone (AM-1155) against chronic airway infection with Pseudomonas aeruginosa in a rat model.
Topics: Animals; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Gatifloxacin; Immunoglobulin A; Immunoglobulin G; Male; Piperazines; Pseudomonas Infections; Quinolones; Rats; Rats, Sprague-Dawley; Tracheal Diseases | 1997 |
Sparfloxacin and levofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones | 1997 |
Effects of the combination antibiotic--EDTA-Tris in the treatment of chronic bovine endometritis caused by antimicrobial-resistant bacteria.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Cattle Diseases; Chronic Disease; Drug Resistance, Microbial; Edetic Acid; Endometritis; Enrofloxacin; Female; Fluoroquinolones; Instillation, Drug; Lincomycin; Oxytetracycline; Quinolones; Solutions; Spectinomycin; Tromethamine; Uterus | 1997 |
Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide.
Topics: Acute Disease; Alanine; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Anticoagulants; Chronic Disease; Colitis; Colonoscopy; Dextran Sulfate; Drug Administration Schedule; Leukocyte Count; Male; Peroxidase; Quinolones; Rats; Rats, Sprague-Dawley | 1998 |
Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Chronic Disease; Dog Diseases; Dogs; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Otitis Externa; Pseudomonas; Pseudomonas Infections; Quinolones; Tobramycin | 2000 |
Treatment of chronic asthma in children: the changing role of inhaled corticosteroids.
Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Chronic Disease; Cromolyn Sodium; Humans; Nedocromil; Quinolones | 1992 |
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Chronic Disease; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Quinolones; Respiratory Tract Infections; Sputum | 1992 |
[New quinolones in urological diseases of an inflammatory nature].
Topics: Acute Disease; Chronic Disease; Humans; Inflammation; Male; Quinolones; Urinary Tract Infections | 1991 |
Quality of life in multi-centre trials.
Topics: Asthma; Chronic Disease; Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Nedocromil; Quality of Life; Quinolones; Surveys and Questionnaires | 1991 |